GILD
Gilead Sciences, Inc.
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $31.0B | +3.6% |
| Gross profit | $24.8B | +2.9% |
| Operating income | −$2.4B | +19.7% |
| Net income | −$3.9B | +133.3% |
| EPS | −$3.16 | +132.4% |
| Free cash flow | $13.8B | +4.7% |
Gilead Sciences, Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $31.0B | +3.6% |
| Gross profit | $24.8B | +2.9% |
| Operating income | −$2.4B | +19.7% |
| Net income | −$3.9B | +133.3% |
| EPS | −$3.16 | +132.4% |
| Free cash flow | $13.8B | +4.7% |